Medical News

RSS

Texas McAllen Hospitals violates the False Claims Act, to pay $27.5M for settling allegations

A hospital group based in McAllen, Texas, has agreed to pay the United States $27.5 million to settle claims that it violated the False Claims Act, the Anti-Kickback Statute and the Stark Statute between 1999 and 2006, by paying illegal compensation to doctors in order to induce them to refer patients to hospitals within the group, the Justice Department announced today.

31 Oct 2009

Replenish+ delays the progression of AIDS in HIV-infected patients not receiving ART

Data presented today from a 310 patient, 52 week, double-blind, controlled clinical trial demonstrates that a micronutrient supplement, Replenish+™ delays the progression of AIDS in HIV-infected patients not receiving antiretroviral treatment (ART).

31 Oct 2009

Revised standards for four ingredients widely used in prescription and over-the-counter drugs announced

To further protect patients from adulterated medicines, the U.S. Pharmacopeial Convention (USP) today announced revised standards for four ingredients widely used in prescription and over-the-counter drugs.

31 Oct 2009

AARP praises General Assembly for preserving critical health care program

Older adults increasingly feeling the pinch of the recession got a significant break from the Illinois General Assembly, as legislators overrode a partial veto from Gov. Quinn on Thursday, preserving a program aimed at helping Medicare beneficiaries afford prescription drugs.

31 Oct 2009

NovaBay Pharmaceuticals' Aganocide compounds demonstrate potent antifungal activity against onychomycosis

NovaBay Pharmaceuticals, Inc. today announced that its Aganocide® compounds demonstrate potent antifungal activity in an established pre-clinical infected nail model of onychomycosis. The study data will be presented tomorrow at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA) in Philadelphia.

31 Oct 2009

Geron plans to advance clinical program for spinal cord injury

Geron Corporation today announced the company’s plan to advance clinical development of its human embryonic stem cell (hESC)-based product, GRNOPC1, for the treatment of spinal cord injury.

31 Oct 2009

MedImpact to provide a suite of free, online flu self-assessment tools

MedImpact has collaborated with the American Medical Association (AMA) and other health care organizations to provide a suite of free, online flu self-assessment tools to MedImpact clients and to the 32 million individual members they serve.

31 Oct 2009

Procter & Gamble's Vicks products containing vitamin C being marketed unlawfully, FDA warns

The U.S. Food and Drug Administration today sent a warning letter to Procter & Gamble notifying the company that its Vicks DayQuil Plus Vitamin C and Vicks Nyquil Plus Vitamin C are illegally marketed combinations of drug ingredients and a dietary ingredient.

31 Oct 2009

New teleneurology medicine program to provide 24-hour emergency services launched

Rural and small, suburban hospitals in North Carolina and Virginia can now provide a higher level of emergency stroke and critical neurology care, 24 hours a day, 365 days a year, as part of a new teleneurology medicine program announced Oct. 26, 2009, by Forsyth Medical Center (FMC).

31 Oct 2009

Male attraction operates differently from female attraction, regardless of sexual orientation

A new study from a researcher at Harvard University finds that gay men are most attracted to the most masculine-faced men, while straight men prefer the most feminine-faced women.

31 Oct 2009

Genetic susceptibility study for Barrett's esophagus and esophageal adenocarcinoma awarded $7.9M grant

Thomas Vaughan, M.D., head of the Epidemiology Program in the Public Health Sciences Division of Fred Hutchinson Cancer Research Center, has received a three-year, $7.9 million grant from the National Cancer Institute to study genetic susceptibility for Barrett's esophagus and esophageal adenocarcinoma, a rapidly fatal cancer whose incidence has increased more than 500 percent in the past 30 years, faster than any other cancer in the United States.

31 Oct 2009

Muslim civil rights organization says 'no hat' policy must have religious exemption

The Council on American-Islamic Relations (CAIR) today called on a major medical group in Texas to change its policy denying accommodation for Muslim employees who wear religious attire such as Islamic head scarves (hijab) or beards.

31 Oct 2009

Illinois aims to protect consumers in the private health insurance market

While the U.S. Congress is still working to strike a comprehensive health reform package, Illinois is leading the way for the rest of the nation with legislation aimed at helping consumers who are forced to go the private insurance market to get the care they need.

31 Oct 2009

Vigilanz, Orlando Health and Contra Costa Regional Medical Center sign license agreement

VigiLanz Corporation has entered into contracts with Orlando Health, Inc., a group of seven hospitals in Orlando, Florida; and Contra Costa Regional Medical Center in Martinez, California, to license the VigiLanz product suite, consisting of the Dynamic PharmacoVigilance® (DPV) system, the Dynamic PracticeGuidance™ (DPG) system, and the VigiLanz Infection Control Monitor™ (ICM).

31 Oct 2009

Tufts University receives $185M grant as part of the USAID Emerging Pandemic Threats program

Tufts University has been tapped by the United States Agency for International Development (USAID) as part of a multidisciplinary team that will receive a grant of up to $185-million to create better synergies among veterinarians, doctors, and public health officials in responding to emerging infectious diseases.

31 Oct 2009

FDA approves Covidien's Abbreviated New Drug Application for CII

Covidien, a leading global provider of healthcare products, today announced that its subsidiary, Mallinckrodt Inc., has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for Oral Transmucosal Fentanyl Citrate (CII).

31 Oct 2009

Women may need smaller dose of H1N1 vaccine

THE emergence of the H1N1 swine flu has added urgency to what has become an annual ritual for millions of Americans: getting a flu shot. The good news is that scientists have developed a vaccine against the H1N1 virus. But it is taking much longer than expected to produce the hundreds of millions of doses the government had planned to distribute. And it is still too soon to know how effective the vaccine will be in preventing swine flu.

31 Oct 2009

NCI awards $4.8M for project to measure all the proteins in the human body

An expert in cancer proteomics at Fred Hutchinson Cancer Research Center has received $4.8 million in federal stimulus funding from the National Cancer Institute to co-lead a pilot study to assess the feasibility and scalability of a project that aims to measure all of the proteins in the human body.

31 Oct 2009

FDA-approved drug PEG-ADA shows positive results in relieving major complication of priapism

Thousands of men are afflicted with an embarrassing and painful condition that triggers spontaneous, long-lasting erections. There are limited treatment options, but a solution could be on the way thanks to new research at The University of Texas Health Science Center at Houston.

31 Oct 2009

Pfizer and Wyeth enter into supplemental indenture to amend consent solicitation

Pfizer today announced that it has received the requisite consents to amend certain provisions of the indenture governing the following outstanding debt securities (the Securities) of Wyeth, its wholly owned subsidiary:

31 Oct 2009

Medical News

Texas McAllen Hospitals violates the False Claims Act, to pay $27.5M for settling allegations

Replenish+ delays the progression of AIDS in HIV-infected patients not receiving ART

Revised standards for four ingredients widely used in prescription and over-the-counter drugs announced

AARP praises General Assembly for preserving critical health care program

NovaBay Pharmaceuticals' Aganocide compounds demonstrate potent antifungal activity against onychomycosis

Geron plans to advance clinical program for spinal cord injury

MedImpact to provide a suite of free, online flu self-assessment tools

Procter & Gamble's Vicks products containing vitamin C being marketed unlawfully, FDA warns

New teleneurology medicine program to provide 24-hour emergency services launched

Male attraction operates differently from female attraction, regardless of sexual orientation

Genetic susceptibility study for Barrett's esophagus and esophageal adenocarcinoma awarded $7.9M grant

Muslim civil rights organization says 'no hat' policy must have religious exemption

Illinois aims to protect consumers in the private health insurance market

Vigilanz, Orlando Health and Contra Costa Regional Medical Center sign license agreement

Tufts University receives $185M grant as part of the USAID Emerging Pandemic Threats program

FDA approves Covidien's Abbreviated New Drug Application for CII

Women may need smaller dose of H1N1 vaccine

NCI awards $4.8M for project to measure all the proteins in the human body

FDA-approved drug PEG-ADA shows positive results in relieving major complication of priapism

Pfizer and Wyeth enter into supplemental indenture to amend consent solicitation

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News